Protalix BioTherapeutics PLX
NYSE PLX
$2.54 -0.10 (-3.79%)
As of: Oct 21, 2026 · 2:03 PM EDT

Protalix BioTherapeutics (PLX) Prepaid Assets (2018 - 2025)

Updated

Protalix BioTherapeutics (PLX) reported Prepaid Assets of $394,000 for Q4 2025, down 21.2% from $500,000 a year earlier.

Analysis

Protalix BioTherapeutics (PLX) Prepaid Assets (2018 - 2025) Analysis & Trends

Dating back to Q4 2018, Protalix BioTherapeutics' Prepaid Assets record includes 8 quarters.

  • Prepaid Assets has a five-year compound annual growth rate of -14.1% (FY2020 to FY2025).
  • By year, Prepaid Assets came in at $500,000 in FY2024 (+12.6%), $444,000 in FY2023 (-42.6%), $774,000 in FY2022 (-14.5%) and $905,000 in FY2021 (+7.6%).
  • The Q4 2025 figure ranks as the lowest quarterly Prepaid Assets since Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,134.61 Bn 1,103.20 Bn 19.71 Bn
2 Johnson & Johnson 616.25 Bn 534.77 Bn 17.26 Bn
3 AbbVie 501.45 Bn 474.56 Bn 12.70 Bn
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn
5 Novartis Ag 297.99 Bn 261.98 Bn 11.24 Bn
6 Astrazeneca 261.44 Bn 235.12 Bn 12.86 Bn
7 Amgen 235.87 Bn 191.27 Bn 7.24 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn
9 Pfizer 169.40 Bn 116.05 Bn 10.94 Bn
10 Protalix BioTherapeutics 202.75 Mn 51.37 Mn 12.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 394,000.00
Dec 31, 2024 500,000.00
Dec 31, 2023 444,000.00
Dec 31, 2022 774,000.00
Dec 31, 2021 905,000.00
Dec 31, 2020 841,000.00
Dec 31, 2019 314,000.00
Dec 31, 2018 453,000.00
API Access

Protalix BioTherapeutics Prepaid Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=prepaid-assets&ticker=PLX&period=max&api_key=YOUR_API_KEY